Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1Anita A. Pinar, Chrishan S. Samuel|Frontiers in Pharmacology|2020Cited by 33